Clinical trial data can be enormously useful, but it's even more paramount to make sure it's sufficiently de-anonymized first before release. We help identify and evaluate some of these methods, and discuss their efficacy in this paper: https://t.co/EAj3x
10 followers
443 followers
RT @cochranemthds: Evaluating the re-identification risk of a clinical study report anonymized under EMA Policy 0070 & Health Canada Regula…
1,479 followers
RT @cochranemthds: Evaluating the re-identification risk of a clinical study report anonymized under EMA Policy 0070 & Health Canada Regula…
6,675 followers
Evaluating the re-identification risk of a clinical study report anonymized under EMA Policy 0070 & Health Canada Regulations - Janice Branson, Nathan Good, Jung-Wei Chen, Will Monge, Christian Probst & Khaled El Emam: https://t.co/YKPgO2ASon